What Clinical Trials Show In clinical trials of FDA-approved semaglutide (Wegovy) and tirzepatide (Zepbound): Semaglutide (Wegovy): In large clinical trials of FDA-approved products, average weight loss was meaningful over roughly 68 weeks when paired with lifestyle support (reduced-calorie diet and increased physical activity)
doi: 10.1074/jbc.RA118.006670
The difference in how I feel day to day is hard to describe
Understanding musculoskeletal side effects from the tirzepatide experience can help you differentiate between expected transitional effects and genuine concerns
Ever since Ozempic entered the market in 2018 to treat diabetes, the GLP-1 market has exploded
Clinical trials have linked semaglutide, for example, with improvements in chronic kidney disease, blood pressure, certain types of heart failure, and even cognitive decline